"We hijack a portion of the energy produced by the microalgae from their photosynthetic systems. By redirecting that energy to a genetically modified part of the cell capable of producing various complex chemical materials, we induce the light driven biosynthesis of these compounds," said Agnieszka Janina Zygadlo Nielsen, from the University of Copenhagen in Denmark.
The researchers successfully modified microalgae to form complex molecules to an unprecedented extent, an advance that may lead to an inexpensive and environmental friendly method of producing chemicals such as pharmaceutical compounds.
"A cancer drug like Taxol for instance is made from old yew trees, which naturally produce the substance in their bark. It is a cumbersome process which results in expensive treatments. If we let the microalgae run the production this problem could be obsolete," Nielsen said.
The method can be run sustainably and continuously, and this is what makes it even more spectacular compared to present methods, said Thiyagarajan Gnanasekaran, from University of Copenhagen.
"Theoretically, the water could be replaced with sewage water, which could make the process run on entirely renewable energy and nutrient sources," he said.
"Recycling wastewater from industry and cities to produce valuable substances would surely be positive," he added.
"If we can create a closed system that produces the valued chemicals from water, sunlight and carbon dioxide, it would be a fully competitive method compared to the ones used today, where it is primarily extracted from plants or yeast and E coli bacteria producing the substances," said Nielsen.
"It is difficult to produce large quantities of the desired compounds in microalgae because they have to use a large amount of the produced energy for themselves, since they are fully photosynthetic organisms," Gnanasekaran said.
"Exactly for this reason, it makes good sense to have them produce the particularly valuable substances which are cost effective to produce in relatively small quantities at a time, as for instance medicine," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
